Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01773096 · ClinicalTrials.gov registry record · Phase 4
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
A Phase 4 study, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01773096: Completed Phase 4 study, sponsored by Shriners Hospitals for Children.
NCT01773096 is a Phase 4 study that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01773096, a Phase 4 study, has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
Interventions
- DRUG Methylnaltrexone
- DRUG Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-05 |
| Phase | Phase 4 |
What the finished NCT01773096 record still lists
NCT01773096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Methylnaltrexone is the first listed.
NCT01773096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01773096 about?
NCT01773096 is a clinical study titled "Methylnaltrexone Use for Opioid-induced Postoperative Constipation". The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
What is the current status of trial NCT01773096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-05. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01773096?
The interventions under investigation include: Methylnaltrexone (DRUG), Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax (DRUG).
Who is sponsoring clinical trial NCT01773096?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01773096's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia